Vamil Divan
Stock Analyst at Guggenheim
(4.81)
# 499
Out of 5,074 analysts
948
Total ratings
56.9%
Success rate
12.9%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JBIO Jade Biosciences | Reiterated: Buy | $47 | $14.07 | +234.04% | 11 | Oct 16, 2026 | |
| AMGN Amgen | Maintained: Hold | $388 → $378 | $402.98 | -6.20% | 10 | Oct 13, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $288 | $265.76 | +8.37% | 131 | Oct 9, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $89 | $57.67 | +54.33% | 32 | Oct 7, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $287 | $252.93 | +13.47% | 56 | Oct 7, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $119 | $72.58 | +63.96% | 23 | Oct 6, 2026 | |
| ENTX Entera Bio | Initiated Coverage: Buy | $11 | $2.62 | +319.85% | 1 | Sep 24, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $146 → $170 | $139.54 | +21.83% | 52 | Sep 8, 2026 | |
| ELOX Eloxx Pharmaceuticals | Reiterated: Buy | $43 | $15.41 | +179.04% | 2 | Aug 23, 2026 | |
| STO: VICO Vicore Pharma Holding AB (publ) | Reiterated: Buy | kr 38.00 | kr 8.89 | +327.45% | 3 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $1.55 | +482.52% | 1 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.78 | +130.13% | 11 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $22.74 | +89.09% | 13 | Aug 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $29.83 | +154.78% | 16 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.82 | +89.17% | 10 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $25 | $4.19 | +496.66% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 → $205 | $103.83 | +97.44% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $31 | $27.41 | +13.10% | 119 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $5.03 | -40.36% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $11.53 | +30.10% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.50 | +220.00% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $1.58 | n/a | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.56 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | €9.23 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.65 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $26 | $3.48 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $88.04 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,143.12 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.13 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $177.08 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $7.47 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $20.11 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $42.76 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $2.08 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $108.31 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $726.47 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $35.78 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $136 | $39.51 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $503.50 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $144.21 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $25.15 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $31.50 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.65 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.16 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $55 | $58.81 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $29.51 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $86.30 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $10.74 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $223.59 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $1.20 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $4.58 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $293.69 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $144.63 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $171.29 | n/a | 1 | Mar 5, 2013 |
Jade Biosciences
Oct 16, 2026
Reiterated: Buy
Price Target: $47
Current: $14.07
Upside: +234.04%
Amgen
Oct 13, 2026
Maintained: Hold
Price Target: $388 → $378
Current: $402.98
Upside: -6.20%
AbbVie
Oct 9, 2026
Reiterated: Buy
Price Target: $288
Current: $265.76
Upside: +8.37%
Travere Therapeutics
Oct 7, 2026
Reiterated: Buy
Price Target: $89
Current: $57.67
Upside: +54.33%
Johnson & Johnson
Oct 7, 2026
Reiterated: Buy
Price Target: $287
Current: $252.93
Upside: +13.47%
ANI Pharmaceuticals
Oct 6, 2026
Reiterated: Buy
Price Target: $119
Current: $72.58
Upside: +63.96%
Entera Bio
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $2.62
Upside: +319.85%
Merck & Co.
Sep 8, 2026
Reiterated: Buy
Price Target: $146 → $170
Current: $139.54
Upside: +21.83%
Eloxx Pharmaceuticals
Aug 23, 2026
Reiterated: Buy
Price Target: $43
Current: $15.41
Upside: +179.04%
Vicore Pharma Holding AB (publ)
Aug 21, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: kr 8.89
Upside: +327.45%
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $1.55
Upside: +482.52%
Aug 20, 2026
Reiterated: Buy
Price Target: $11
Current: $4.78
Upside: +130.13%
Aug 16, 2026
Reiterated: Buy
Price Target: $43
Current: $22.74
Upside: +89.09%
Aug 14, 2026
Reiterated: Buy
Price Target: $76
Current: $29.83
Upside: +154.78%
Aug 13, 2026
Reiterated: Buy
Price Target: $11
Current: $5.82
Upside: +89.17%
Aug 12, 2026
Reiterated: Buy
Price Target: $37 → $25
Current: $4.19
Upside: +496.66%
Aug 6, 2026
Reiterated: Buy
Price Target: $207 → $205
Current: $103.83
Upside: +97.44%
Aug 6, 2026
Reiterated: Buy
Price Target: $35 → $31
Current: $27.41
Upside: +13.10%
Jul 1, 2026
Reiterated: Buy
Price Target: $5 → $3
Current: $5.03
Upside: -40.36%
Jun 25, 2026
Reiterated: Buy
Price Target: $15
Current: $11.53
Upside: +30.10%
Mar 20, 2026
Reiterated: Buy
Price Target: $8
Current: $2.50
Upside: +220.00%
Jul 13, 2025
Reiterated: Buy
Price Target: $6 → $7
Current: $1.58
Upside: n/a
May 29, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.56
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: €9.23
Upside: n/a
May 6, 2024
Reiterated: Hold
Price Target: n/a
Current: $10.65
Upside: n/a
Jun 15, 2023
Reiterated: Buy
Price Target: $50 → $26
Current: $3.48
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $88.04
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,143.12
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $10.13
Upside: n/a
Jun 27, 2022
Reiterated: Buy
Price Target: $49
Current: $177.08
Upside: n/a
Jun 21, 2022
Reiterated: Buy
Price Target: $15
Current: $7.47
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $20.11
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $42.76
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $20 → $10
Current: $2.08
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $108.31
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $726.47
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $35.78
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $136
Current: $39.51
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $503.50
Upside: n/a
May 4, 2022
Reiterated: Hold
Price Target: $95
Current: $144.21
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $25.15
Upside: n/a
May 7, 2021
Reiterated: Buy
Price Target: $37
Current: $31.50
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $3.65
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $1.16
Upside: n/a
May 29, 2019
Reiterated: Hold
Price Target: $59 → $55
Current: $58.81
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $29.51
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $86.30
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $10.74
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $223.59
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $1.20
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $4.58
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $293.69
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $144.63
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $171.29
Upside: n/a